Tech Company Financing Transactions

Nereus Pharmaceuticals Funding Round

Nereus Pharmaceuticals closed a $42.6 million Series D funding round on 1/4/2005. Investors included HBM Healthcare Investments, Advent International and Alta Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10480 Wateridge Cir.
San Diego, CA 92121
USA

Phone

(858) 587-4090

Website

www.nereuspharm.com

Email Address

[email protected]

Overview

Nereus Pharmaceuticals is an innovative drug discovery and development company pursuing untapped sources of chemical diversity.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kobi Sethna

        

Chief Information Officer

Gary McDaniel

        

Chief Medical Officer

Matthew Spear

        

Chief Scientific Officer

Kenneth Lloyd

        

Chief Technical Officer

Michael Palladino

        

VP - Finance

Donald Salz

        

VP - Regulatory Affairs

Howard Holden

        

Browse more venture capital transactions:

Prev: 1/2/2005: Commil venture capital transaction
Next: 1/4/2005: XMPie venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary